Back
ProKidney Corp. 10K Form
Sell
36
PROK
ProKidney Corp.
Last Price:
$1.92
Seasonality Move:
5.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PROK News And Ratings
See the #1 stock for the next 7 days that we like better than PROK
PROK Financial Statistics
Sales & Book Value
| Annual Sales: | $893K |
|---|---|
| Cash Flow: | $-38.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-7.13 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.51520 |
|---|---|
| Net Income (TTM): | $-151.6M |
| Gross Margin: | $-4.8M |
| Return on Equity: | -43.81% |
| Return on Assets: | -39.74% |
ProKidney Corp. Earnings Forecast
Key ProKidney Corp. Financial Ratios
-
The Gross Profit Margin over the past 5 years for PROK is -540.76%.
-
The Selling, General & Administrative Expenses for PROK have been equal to 5,798.10% of Gross Profit Margin.
-
The Research & Development expenses have been 12,779.73% of Revenue.
-
The Net Earning history of PROK is -16,977.83% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 2 years.
ProKidney Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PROK |
| Website: | prokidney.com |
Debt
| Debt-to-Equity Ratio: | -0 |
|---|---|
| Current Ratio: | 9.13 |
| Quick Ratio: | 8.78 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PROK Technical Analysis vs Fundamental Analysis
Sell
36
ProKidney Corp. (PROK)
is a Sell
Is ProKidney Corp. a Buy or a Sell?
-
ProKidney Corp. stock is rated a SellThe current ProKidney Corp. [PROK] share price is $1.90. The Score for PROK is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.